163 related articles for article (PubMed ID: 36275363)
1. STAG2 expression is associated with adverse survival outcomes and regulates cell phenotype in muscle-invasive bladder cancer.
Athans S; Krishnan N; Ramakrishnan S; Cortes Gomez E; Lage-Vickers S; Rak M; Kazmierczak Z; Ohm J; Attwood K; Wang J; Woloszynska A
Cancer Res Commun; 2022 Oct; 2(10):1129-1143. PubMed ID: 36275363
[TBL] [Abstract][Full Text] [Related]
2. The role of STAG2 in bladder cancer.
Aquila L; Ohm J; Woloszynska-Read A
Pharmacol Res; 2018 May; 131():143-149. PubMed ID: 29501732
[TBL] [Abstract][Full Text] [Related]
3. Frequent truncating mutations of STAG2 in bladder cancer.
Solomon DA; Kim JS; Bondaruk J; Shariat SF; Wang ZF; Elkahloun AG; Ozawa T; Gerard J; Zhuang D; Zhang S; Navai N; Siefker-Radtke A; Phillips JJ; Robinson BD; Rubin MA; Volkmer B; Hautmann R; Küfer R; Hogendoorn PC; Netto G; Theodorescu D; James CD; Czerniak B; Miettinen M; Waldman T
Nat Genet; 2013 Dec; 45(12):1428-30. PubMed ID: 24121789
[TBL] [Abstract][Full Text] [Related]
4. Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes.
Taylor CF; Platt FM; Hurst CD; Thygesen HH; Knowles MA
Hum Mol Genet; 2014 Apr; 23(8):1964-74. PubMed ID: 24270882
[TBL] [Abstract][Full Text] [Related]
5. Loss of STAG2 causes aneuploidy in normal human bladder cells.
Li X; Zhang TW; Tang JL; Fa PP; Lu JX; Qi FM; Cai ZM; Liu CX; Sun XJ
Genet Mol Res; 2015 Mar; 14(1):2638-46. PubMed ID: 25867412
[TBL] [Abstract][Full Text] [Related]
6. Stromal antigen 2 functions as a tumor suppressor in bladder cancer cells.
Wang H; Zhong J; Wu C; Liu Y; Zhang J; Zou X; Chen Y; Su J; Yang G; Zhong Y; Tang A
Oncol Rep; 2017 Aug; 38(2):917-925. PubMed ID: 28627627
[TBL] [Abstract][Full Text] [Related]
7. Identification of STAG2-Mutant Bladder Cancers by Immunohistochemistry.
Park Y; Lelo A; Harris B; Berry DL; Chaldekas K; Kim JS; Waldman T
Methods Mol Biol; 2023; 2684():145-151. PubMed ID: 37410232
[TBL] [Abstract][Full Text] [Related]
8. Intact Cohesion, Anaphase, and Chromosome Segregation in Human Cells Harboring Tumor-Derived Mutations in STAG2.
Kim JS; He X; Orr B; Wutz G; Hill V; Peters JM; Compton DA; Waldman T
PLoS Genet; 2016 Feb; 12(2):e1005865. PubMed ID: 26871722
[TBL] [Abstract][Full Text] [Related]
9. Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.
Balbás-Martínez C; Sagrera A; Carrillo-de-Santa-Pau E; Earl J; Márquez M; Vazquez M; Lapi E; Castro-Giner F; Beltran S; Bayés M; Carrato A; Cigudosa JC; Domínguez O; Gut M; Herranz J; Juanpere N; Kogevinas M; Langa X; López-Knowles E; Lorente JA; Lloreta J; Pisano DG; Richart L; Rico D; Salgado RN; Tardón A; Chanock S; Heath S; Valencia A; Losada A; Gut I; Malats N; Real FX
Nat Genet; 2013 Dec; 45(12):1464-9. PubMed ID: 24121791
[TBL] [Abstract][Full Text] [Related]
10. STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer.
Lelo A; Prip F; Harris BT; Solomon D; Berry DL; Chaldekas K; Kumar A; Simko J; Jensen JB; Bhattacharyya P; Mannion C; Kim JS; Philips G; Dyrskjøt L; Waldman T
Clin Cancer Res; 2018 Sep; 24(17):4145-4153. PubMed ID: 29954776
[No Abstract] [Full Text] [Related]
11. Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
Pietzak EJ; Zabor EC; Bagrodia A; Armenia J; Hu W; Zehir A; Funt S; Audenet F; Barron D; Maamouri N; Li Q; Teo MY; Arcila ME; Berger MF; Schultz N; Dalbagni G; Herr HW; Bajorin DF; Rosenberg JE; Al-Ahmadie H; Bochner BH; Solit DB; Iyer G
Eur Urol; 2019 Feb; 75(2):231-239. PubMed ID: 30290956
[TBL] [Abstract][Full Text] [Related]
12. Frequent truncating mutations of STAG2 in bladder cancer.
Black P
Urology; 2014 Apr; 83(4):691-2. PubMed ID: 24486001
[No Abstract] [Full Text] [Related]
13. Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer.
Qiao Y; Zhu X; Li A; Yang S; Zhang J
Tumour Biol; 2016 Aug; 37(8):10279-86. PubMed ID: 26838030
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer: STAG2 in the spotlight--have genomic studies identified a plausible biomarker?
Razzak M
Nat Rev Urol; 2013 Dec; 10(12):675. PubMed ID: 24189933
[No Abstract] [Full Text] [Related]
15. Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing.
Wang F; Dong X; Yang F; Xing N
Front Genet; 2022; 13():831146. PubMed ID: 35419031
[No Abstract] [Full Text] [Related]
16. STAG2 loss-of-function affects short-range genomic contacts and modulates the basal-luminal transcriptional program of bladder cancer cells.
Richart L; Lapi E; Pancaldi V; Cuenca-Ardura M; Pau EC; Madrid-Mencía M; Neyret-Kahn H; Radvanyi F; Rodríguez JA; Cuartero Y; Serra F; Le Dily F; Valencia A; Marti-Renom MA; Real FX
Nucleic Acids Res; 2021 Nov; 49(19):11005-11021. PubMed ID: 34648034
[TBL] [Abstract][Full Text] [Related]
17. De novo loss-of-function variants in STAG2 are associated with developmental delay, microcephaly, and congenital anomalies.
Mullegama SV; Klein SD; Mulatinho MV; Senaratne TN; Singh K; ; Nguyen DC; Gallant NM; Strom SP; Ghahremani S; Rao NP; Martinez-Agosto JA
Am J Med Genet A; 2017 May; 173(5):1319-1327. PubMed ID: 28296084
[TBL] [Abstract][Full Text] [Related]
18. Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene.
Djos A; Fransson S; Kogner P; Martinsson T
BMC Med Genet; 2013 Oct; 14():102. PubMed ID: 24088605
[TBL] [Abstract][Full Text] [Related]
19. STAG2 Protein Expression in Non-muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes.
Gordon NS; Humayun-Zakaria N; Goel A; Abbotts B; Zeegers MP; Cheng KK; James ND; Arnold R; Bryan RT; Ward DG
Eur Urol Open Sci; 2022 Apr; 38():88-95. PubMed ID: 35495284
[TBL] [Abstract][Full Text] [Related]
20. Mutational inactivation of STAG2 causes aneuploidy in human cancer.
Solomon DA; Kim T; Diaz-Martinez LA; Fair J; Elkahloun AG; Harris BT; Toretsky JA; Rosenberg SA; Shukla N; Ladanyi M; Samuels Y; James CD; Yu H; Kim JS; Waldman T
Science; 2011 Aug; 333(6045):1039-43. PubMed ID: 21852505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
